AiMIFY™
Not Specified
Work in ProgressActive
Key Facts
About Subtle Medical
Subtle Medical is a private, commercial-stage company founded in 2017 as a Stanford spin-out, specializing in AI-powered medical imaging enhancement. It has secured 9 FDA clearances for its software suite, which includes SubtleMR™, SubtlePET™, and the integrated Subtle-ELITE™ package for MRI. With over $50M raised and software deployed on nearly a thousand scanners globally, the company aims to improve radiology workflow efficiency, patient throughput, and safety by reducing scan times and contrast agent dosage. Its leadership combines deep technical AI expertise with clinical radiology experience.
View full company profileOther Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| FL116 | Forlong Biotechnology | Not specified |
| FL117 | Forlong Biotechnology | Not specified |
| FL118 | Forlong Biotechnology | Not specified |
| FL301 | Forlong Biotechnology | Not specified |
| JSKN016 | AlphaMab Oncology | Phase 1 |
| JSKN033 | AlphaMab Oncology | Phase 1 |
| JSKN022 | AlphaMab Oncology | Phase 1 |
| JSKN027 | AlphaMab Oncology | Phase 1 |
| KN019 | AlphaMab Oncology | Phase 1 |
| New TCM Formulations | China SXT Pharmaceuticals | Research / Pre-clinical |
| Long-acting Leronlimab | CytoDyn | Preclinical |
| SR2162 | SIMR (Australia) Biotech | IND Approved |